Cycloartenol

Cycloartenol

SCHEMBL13644393

CC(C)=CCC[C@@H](C)[C@H]1CC[C@@]2(C)C3CC[C@H]4C(C)(C)[C@@H](O)CCC45CC35CCC12C

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACLY P53396 2/20 0.81
▸ ACACA Q13085 2/20 0.81
▸ PTPN11 Q06124 1/20 0.62
▸ USP2 O75604 1/20 0.54
▸ ALDH1A1 P00352 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ MAPT P10636 1/20 0.54
▸ ALOX15 P16050 1/20 0.54
▸ CRYAB P02511 1/20 0.54
▸ HSD11B1 P28845 1/20 0.52
▸ HSD11B2 P80365 1/20 0.52
▸ PTGS1 P23219 1/20 0.51
▸ PTGS2 P35354 1/20 0.51
▸ NR1H3 Q13133 1/20 0.46
▸ ESR2 Q92731 1/20 0.45
▸ ACHE P22303 3/20 0.44
▸ HMGCR P04035 1/20 0.42
▸ PTGES O14684 3/20 0.42
▸ FNTA P49354 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cycloartenol SCHEMBL12368108 1.00 ACLY (0.81) ACLYACACAPTPN11USP2ALDH1A1
Cycloartenol SCHEMBL13455189 1.00 ACLY (0.81) ACLYACACAPTPN11USP2ALDH1A1
Cycloartenol SCHEMBL8283290 1.00 ACLY (0.81) ACLYACACAPTPN11USP2ALDH1A1
Cycloartenol SCHEMBL560780 1.00 ACLY (0.81) ACLYACACAPTPN11USP2ALDH1A1
Cycloartenol SCHEMBL13420259 1.00 ACLY (0.81) ACLYACACAPTPN11USP2ALDH1A1
Cycloartenol SCHEMBL23754759 1.00 ACLY (0.81) ACLYACACAPTPN11USP2ALDH1A1
Cycloartenol SCHEMBL10034117 1.00 ACLY (0.81) ACLYACACAPTPN11USP2ALDH1A1
Cycloartenol SCHEMBL21754440 1.00 ACLY (0.81) ACLYACACAPTPN11USP2ALDH1A1
Cycloartenol SCHEMBL20778271 1.00 ACLY (0.81) ACLYACACAPTPN11USP2ALDH1A1
Cycloartenol SCHEMBL17057018 1.00 ACLY (0.81) ACLYACACAPTPN11USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120283217-A1 MODULATORS OF AMYLOID-BETA PRODUCTION SATORI PHARMACEUTICALS, INC. (US) 2012-11-08 — — US disclosed
WO-2008130449-A2 MODULATORS OF AMYLOID-BETA PRODUCTION SATORI PHARMACEUTICALS, INC. (US) 2008-10-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120283217-A1 MODULATORS OF AMYLOID-BETA PRODUCTION APP, BACE1, BACE2 ACLY 668/4885ACACA 195/4885PTPN11 4386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback